OJRA  Vol.5 No.2 , May 2015
Autoantibodies in Systemic Lupus Erythematosus, on Black African Subject, in Abidjan
Abstract: Aim: To determine the clinical and immunological characteristics of patients with systemic erythematosus lupus in Abidjan. Patients and Method: We studied 117 patients’ files with systemic lupus erythematosus aged 12 to 73 years old, who fulfilled the American College of Rheumatology (ACR)’s criteria. Antinuclear autoantibodies (ANA) were searched by indirect immunofluorescence. Anti-DNA native autoantibodies, extractable nuclear anti-antigens autoantibodies (anti-Sm, anti-SSA, anti-SSB and anti-RNP) and anti-phospholipids autoantibodies have been searched by ELISA technic. Results: The most frequent clinical manifestations were: articular damages (86.32%), cutaneous and mucosal lesions (71.79%) and fever (76.67%). Kidney damages have been noticed in 40.17%. Neurologic manifestations have been observed in 36.75%. Pericarditis and pleurisies have been noticed in 22.22% and 11.97% of cases, and anaemia in 86.32% of cases. ANA have been detected in 94.12% of cases, anti-DNA native’s autoantibodies in 73.53% and anti-Sm autoantibodies in 75% of cases. Anti-SSA and anti-SSB autoantibodies were respectively in 75% and 56.25% of cases. Anti-RNP autoantibodies were in all the patients, and anti-phospholipids autoantibodies were in 37.50% of cases. Conclusion: Systemic lupus erythematosus of Ivorian black subject is characterised by high prevalence of autoantibodies, mostly Anti-RNP.
Cite this paper: Gbané-Koné, M. , Ouattara, B. , Djaha, K. , Megne, E. , Ngandeu, A. , Coulibaly, A. , Eti, E. and Kouakou, M. (2015) Autoantibodies in Systemic Lupus Erythematosus, on Black African Subject, in Abidjan. Open Journal of Rheumatology and Autoimmune Diseases, 5, 28-35. doi: 10.4236/ojra.2015.52006.

[1]   Haddouk, S., Ben Ayed, M., Baklouti, S., Hachicha, J., Bahloul, Z. and Masmoudi, H. (2005) Autoanticorps dans le lupus érythémateux systémique : Profil et corrélations cliniques . Pathologie Biologie, 53, 311-317.

[2]   Ghedira, I., Sakly, W. and Jeddi, M. (2002) Caractéristiques cliniques et sérologiques du lupus érythémateux systémique: A propos de 128 cas. Pathologie Biologie, 50, 18-24.

[3]   Meyer, O. (2002) Lupus systémique chez les non-Caucasiens. Revue du Rhumatisme, 69, 801-808.

[4]   Daboiko, J.C., Gueret, M., Eti, E., Ouali, B., Ouattara, B., Gbané, M. and Kouakou, N.M. (2004) Profil clinique et évolutif du lupus érythémateux systémique: A propos de 49 cas colligés au CHU de Cocody. Médecine d’Afrique noire, 51, 143-146.

[5]   Iba Ba, J., Nzenze, J.R., Biteghe, B., Missounga, L., Bignoumba Ibouili, R., Moussavou Kombila, J.B. and Boguikouma, J.B. (2011) Profil clinique, biologique et évolutif du lupus systémique en milieu hospitalier à Libreville. Médecine d’Afrique noire, 58, 551-559.

[6]   Fall, S., Pouye, A., Ndiaye, F.S., Ndongo, S., Leye,Y., Diouma,A., Dieng, M.T., Ka, E.F., Ka, M.M. and Moreira-Diop, T. (2011) Présentation initiale du lupus érythémateux systémique au Sénégal. Médecine d’Afrique noire, 58, 156-160.

[7]   Doualla Bija, M., Luma Namme, H., Ashuntantang, G., Epée, H., Kemta, F., Kwedi, F., Ngatat, C. and Ngandeu Singwe, M. (2014) Clinical Presentation, Treatment and Outcome of Patients with Systemic Lupus Erythematosus Seen at a Rheumatology Clinic in Douala, Cameroon. Health Sciences and Disease, 15, 1-5.

[8]   Bouatba, L., Bachir, H., Ammouri, W., Maamar, M., Harmouche, H., Adnaoui, M. and Tazi Mezalek, Z. (2014) Lupus érythémateux systémique au Maroc: Etude analytique monocentrique de 440 patients. Revue de médecine interne, 35, A96-A200.

[9]   Louzir, B., Othmani, S. and Ben Abdelhafidh, N. (2003) Le lupus érythémateux systémique en Tunisie. étude multi- centrique nationale. à propos de 295 observations. La revue de médecine interne, 24, 768-774.

[10]   Vilá, L.M., Mayor, A.M., Valentín, A.H., Garcia-Soberal, M. and Vilá, S. (1999) Clinical and Immunological Manifestations in 134 Puerto Rican Patients with Systemic Lupus Erythematosus. Lupus, 8, 279-286.

[11]   Al-Attia, H.M. and Al-Ahmed, Y.H. (1998) Mucocutaneous Disease in Arabs with SLE: Clinical Expression and Relevance to Autoantibodies. Lupus, 7, 535-539.

[12]   Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., et al. (1993) Systemic Lupus Erythematosus: Clinical and Immunological Patterns of Disease Expression in a Cohort of 1000 Patients. The European Working Party on Systemic Lupus Erythematosus. Medicine, 72, 113-124.

[13]   Al Mekaimi, A., Malaviya, A.N., Serebour, F., Umamaheswaran, I., Kumar, R., Al-Saeid, K. and Sharma, P. (1997) Serological Characteristics of Systemic Lupus Erythematosus from a Hospital-Based Rheumatology Clinic in Kuwait. Lupus, 6, 668-674.

[14]   West, S.G. (1996) Lupus and the Central Nervous System. Current Opinion in Rheumatology, 8, 408-414.

[15]   ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes. Arthritis & Rheumatology, 42, 599-608.

[16]   Uthman, I., Nasr, F., Kassak, K. and Masri, A.B. (1999) Systemic Lupus Erythematosus in Lebanon. Lupus, 8, 713-715.

[17]   Petri, M. (1997) The Effect of Race on the Presentation and Course of SLE in the United States. Arthritis & Rheumatology, 40, S162.

[18]   Al-Jarallah, K., Al-Awadi, A., Siddiqui, H., Al-Salim, I., Shehab, D., Umamaheswaran, I., et al. (1998) Systemic Lupus Erythematosus in Kuwait Hospital Based Study. Lupus, 7, 434-438.

[19]   Vilarinho, S.T. and Lavras-Costallat, L.T. (1998) Evaluation of the Hypothalamic-Pituitary-Gonadal Axis in Males with Systemic Lupus Erythematosus. Journal of Rheumatology, 25, 1097-103.

[20]   Meyer, O., Lupus érythémateux aigu disséminé (1997) Diagnostic, évolution, principes du traitement. Revue du Praticien, 47, 821-831.

[21]   Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., Mc Shane, D.J., Rothfield, N.F., et al. (1982) The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis & Rheumatology, 25, 1271-1277.

[22]   Chahade, W.H., Sato, E.L., Moura, J.E., Costallat, L.T.L. and Andrate, L.E.C. (1995) Systemic Lupus Erythematosus in Sao Paulo/Brazil: A Clinical and Laboratory Overview. Lupus, 4, 100-103.

[23]   Molina, J.F., Molina, J., Garcia, C., Gharavi, A.E., Wilson, W.A. and Espinoza, L.R. (1997) Ethnic Differences in the Clinical Expression of Systemic Lupus Erythematosus: A Comparative Study between African-American and Latin American. Lupus, 6, 63-67.

[24]   Lopez-Longo, F.J., Monteagudo, I., Gonzalez, C.M., Grau, R. and Carreno, L. (1998) Anti-BB’-Sm Antibodies, Anticardiolipin Antibodies and Thrombosis in Systemic Lupus Erythematosus. The Journal of Rheumatology, 25, 1743- 1749.

[25]   Lenert, P., Felle, D., Lenert, G., Mitic, I., Curic, S. and Vodopivec, S. (1993) Immunologic Characterization of Autoreactivity to Nuclear Antigens in Patients with Systemic Lupus Erythematosus. Medicinski Pregled, 46, 167-172.

[26]   Fournel, S. and Levastre, P. (2000) Les autoanticorps dans le lupus. Médecine Thérapeutique, 6, 537-546.

[27]   Pan, L.T., Tin, S.K., Boey, M.L. and Fong, K.Y. (1998) The Sensitivity and Specificity of Auto-Antibodies to the Sm Antigen in the Diagnosis of Systemic Lupus Erythematosus. Annals Academy of Medicine Singapore, 27, 21-23.

[28]   Meyer, O. (1999) Biologie du lupus érythémateux systémique. Revue du Rhumatisme, 66, 75s-80s.

[29]   Goetz, M. (2005) Marqueurs biologiques anciens et modernes du lupus erythémateux systémique. Revue du Rhumatisme, 72, 134-141.

[30]   Amoura, Z., Du, L.T.H., Cacoub, P., Frances, C. and Piette, J.C. (1999) Systemic Lupus Erythematosus in Patients Native to West and Central Africa: Comment on the Article by Bae et al. Arthritis & Rheumatism, 42, 1560-1561.<1560::AID-ANR42>3.0.CO;2-L

[31]   Morrisson, R.C.A., Gear, A.J., Kark, A., Meyers, A. and Goldberg, B. (1990) Differences in Systemic Lupus Erythematosus among 4 Racial Groups in South Africa. Arthritis & Rheumatism, 33, S104.

[32]   Simmons-O’Brien, E., Chen, S., Watson, R., Antoni, C., Petri, M., Hochberg, M., et al. (1995) One Hundred Anti-Ro (SS-A) Antibody Positive Patients: A 10 Year Follow-Up. Medicine, 74, 109-130.

[33]   Buján, S., Ordi-Ros, J., Paredes, J., Mauri, M., Matas, L., Cortés, J. and Vilardell, M. (2003) Contribution of the Initial Features of Systemic Lupus Erythematosus to the Clinical Evolution and Survival of a Cohort of Mediterranean Patients. Annals of the Rheumatic Diseases, 62, 859-865.